Search results
Showing results for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Research Assistant in Immunology and Inflammation (185107)
With several clinical studies currently active in the lab you will be part of the team investigating the cellular and molecular response of patients to standard of care treatments and biologics for diseases including Rheumatoid Arthritis and Inflammatory Bowel Disease.
Meet Chris
-
Christopher Buckley
Kennedy Professor of Translational Rheumatology and Director of Clinical Research
